AstraZeneca Pharma India has entered into an exclusive distribution agreement with New Delhi- based Mankind Pharma for its budesonide and formoterol fumarate dihydrate (inhaled corticosteroid and long-acting beta-agonist combination) brand Symbicort in India. Under the agreement, AstraZeneca will retain intellectual property rights and remain the Marketing Authorization Holder and...
AstraZeneca Brings Rare Disease Therapy to India
AstraZeneca India announced its entry into rare disease therapy in India. The company received regulatory approval for its ‘Selumetinib’ for patients in India. Globally, more than 400 million people are affected by rare diseases, and currently, there are 7,000 identified and recorded rare diseases. AstraZeneca has partnered the Organization of...